Procter & Gamble Health Ltd (PGHL):企業の財務・戦略的SWOT分析

◆英語タイトル:Procter & Gamble Health Ltd (PGHL) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0256
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Consumer Packaged Goods
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Procter & Gamble Health Ltd (PGHL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Procter & Gamble Health Ltd (Procter & Gamble), formerly Merck Limited, is a manufacturer and marketer of pharmaceutical products. The company offers over-the-counter products, minerals, vitamins and supplements for consumers. It markets products under the brand names: Neurobion, Polybion, Evion, Livogen Nasivion, and Seven Seas. The company manufacturers its products at company owned production facility in Goa, India and third-party managed production sites. It exports pharmaceutical products to Asian countries such as Singapore, Bangladesh, Maldives, Myanmar and Sri Lanka; and outside Asia. The company also exports Active Pharmaceutical Ingredients (APIs) to Thailand and Austria. Procter & Gamble is headquartered in Mumbai, Maharashtra, India.

Procter & Gamble Health Ltd Key Recent Developments

Jun 03,2019: Procter & Gamble Health: Change in Directorate
May 07,2019: Merck renamed as Procter & Gamble Health
Jan 24,2019: Merck: Allotment of Director identification number to Mr. Hon Keong Choo and effective date of appointment of Mr. Hon Keong Choo
Dec 10,2018: Merck announces management changes
Aug 28,2018: Combination approach shows promise for beating advanced melanoma

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Procter & Gamble Health Ltd – Key Facts
Procter & Gamble Health Ltd – Key Employees
Procter & Gamble Health Ltd – Major Products and Services
Procter & Gamble Health Ltd – History
Procter & Gamble Health Ltd – Company Statement
Procter & Gamble Health Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Procter & Gamble Health Ltd – Business Description
Geographical Segment: Domestic
Performance
Geographical Segment: Export
Performance
Procter & Gamble Health Ltd – SWOT Analysis
SWOT Analysis – Overview
Procter & Gamble Health Ltd – Strengths
Procter & Gamble Health Ltd – Weaknesses
Procter & Gamble Health Ltd – Opportunities
Procter & Gamble Health Ltd – Threats
Procter & Gamble Health Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Procter & Gamble Health Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jun 03, 2019: Procter & Gamble Health: Change in Directorate
May 07, 2019: Merck renamed as Procter & Gamble Health
Jan 24, 2019: Merck: Allotment of Director identification number to Mr. Hon Keong Choo and effective date of appointment of Mr. Hon Keong Choo
Dec 10, 2018: Merck announces management changes
Aug 28, 2018: Combination approach shows promise for beating advanced melanoma
Aug 07, 2018: Merck’s Head of Human Resources Mirian M. Graddick-Weir to Retire; Steven C. Mizell Will Assume Role on Oct. 1
Jul 26, 2018: Record wind farm construction underway at close of second quarter
Mar 27, 2018: Merck: Appointment of Additional Director and Managing Director
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Procter & Gamble Health Ltd, Key Facts
Procter & Gamble Health Ltd, Key Employees
Procter & Gamble Health Ltd, Major Products and Services
Procter & Gamble Health Ltd, History
Procter & Gamble Health Ltd, Other Locations
Procter & Gamble Health Ltd, Key Competitors
Procter & Gamble Health Ltd, Ratios based on current share price
Procter & Gamble Health Ltd, Annual Ratios
Procter & Gamble Health Ltd, Annual Ratios (Cont...1)
Procter & Gamble Health Ltd, Annual Ratios (Cont...2)
Procter & Gamble Health Ltd, Interim Ratios
Procter & Gamble Health Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Procter & Gamble Health Ltd, Performance Chart (2014 - 2018)
Procter & Gamble Health Ltd, Ratio Charts

★海外企業調査レポート[Procter & Gamble Health Ltd (PGHL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jefferies Group LLC:企業のM&A・事業提携・投資動向
    Jefferies Group LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Jefferies Group LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • PricewaterhouseCoopers LLP (UK):企業の戦略的SWOT分析
    PricewaterhouseCoopers LLP (UK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Cara Therapeutics Inc (CARA):企業の財務・戦略的SWOT分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • Rinnai Corp (5947):企業の財務・戦略的SWOT分析
    Rinnai Corp (5947) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Pharco Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharco Pharmaceuticals Inc (Pharco Pharmaceuticals), a subsidiary of Pharco Corp, is a manufacturer of branded and generic pharmaceutical products. The company offers products such as alambupine, alfatral, amlodipine, amrase, amrizole, bisadyl, bromhexine, carbolase, ciprofloxacin, dexametha …
  • Medical Depot Inc-医療機器分野:企業M&A・提携分析
    Summary Medical Depot Inc (Drive Medical) is a medical device company that manufactures and markets mobility products. The company offers products such as rollators, walkers, canes and crutches; bath safety, commodes, wheelchairs, patient room, beds, power mobility, pressure prevention, electrothera …
  • Pitney Bowes Inc.:企業の戦略・SWOT・財務情報
    Pitney Bowes Inc. - Strategy, SWOT and Corporate Finance Report Summary Pitney Bowes Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Henry Schein Inc (HSIC)-製薬・医療分野:企業M&A・提携分析
    Summary Henry Schein, Inc. (Henry Schein) is a distributor of healthcare products and services. Its product and service portfolio consists of dental products, medical products, animal health products, software and technology and other value-added services. It offers generic and branded pharmaceutica …
  • Pieridae Energy Ltd (PEA):石油・ガス:M&Aディール及び事業提携情報
    Summary Pieridae Energy Ltd (Pieridae Energy), formerly Petrolia Inc, is an oil and gas company that develops, explores, and produces oil resources. The company’s projects comprise Haldimand project, Bourque project, Tar Point project, Corte-Real project, Anticosti project, Dalhousie project; Edgar, …
  • Tyson Foods Inc:戦略・SWOT・企業財務分析
    Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Oneness Biotech Co Ltd (4743):製薬・医療:M&Aディール及び事業提携情報
    Summary Oneness Biotech Co Ltd (Oneness Biotech) is a biopharmaceutical company that conducts research and development of drugs. The company provides products such as anti acne products. Its technologies comprise GAP cultivation platform, medicinal material identification, and separation and purific …
  • Astute Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Astute Medical Inc (Astute Medical), a subsidiary of BioMerieux SA is a diagnostic equipment provider. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • Surface Oncology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Surface Oncology Inc (Surface Oncology) is a biopharmaceutical company that develops novel cancer immunotherapies for the treatment of cancer. The company develops treatments in which the immune system can be harnessed to fight cancer. It conducts pre-clinical study through new approaches to …
  • New Zealand Energy Corp (NZ):石油・ガス:M&Aディール及び事業提携情報
    Summary New Zealand Energy Corp (New Zealand Energy), formerly East Coast Energy Ventures Ltd is an oil and gas company. The company carries out the business of production, development and exploration of conventional and unconventional oil and natural gas prospects in New Zealand. It acquires strate …
  • Maastricht University:医療機器:M&Aディール及び事業提携情報
    Summary Maastricht University (MU) is an educational service provider that offers academic programs such as bachelor degree, master and doctoral programs. The university offers postgraduate research degrees in various subjects for a range of research needs and interests. It offers programs through i …
  • Medigen Vaccine Biologics Corp (6547):製薬・医療:M&Aディール及び事業提携情報
    Summary Medigen Vaccine Biologics Corp (MVC) a subsidiary of Medigen Biotechnology Corp is a biopharmaceutical company with focus on the development and production of vaccines and biologics. Its research and development pipeline includes EV71 vaccine to prevent enterovirus infection; H5N1 and H7N9 m …
  • Cerner Corp (CERN):企業の財務・戦略的SWOT分析
    Cerner Corp (CERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Tryton Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Tryton Medical Inc (Tryton Medical) is a medical device company that develops novel stent systems for the treatment of bifurcation lesions. The company provides tryton side branch coronary artery stent, which is designed to treat, protect and secure coronary bifurcations. Its tryton side bra …
  • Elong Inc:企業の戦略・SWOT・財務分析
    Elong Inc - Strategy, SWOT and Corporate Finance Report Summary Elong Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Scienion AG:医療機器:M&Aディール及び事業提携情報
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆